No Data
No Data
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9
Express News | HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target
Caribou Biosciences: A Strong Buy on Solid Financials and Promising Trials
Express News | Caribou Biosciences Appoints Tina Albertson, Md, Phd, as Chief Medical Officer
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
Bank of America Securities Keeps Their Buy Rating on Caribou Biosciences (CRBU)
No Data